3-hydroxyflavone has been researched along with tamoxifen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Habrioux, G; Le Bail, JC; Nicolas, JC; Varnat, F | 1 |
| Chung, KH; Oh, SM | 1 |
| Cao, T; Guo, CH; Waddington, JL; Zhen, XC; Zheng, LT | 1 |
3 other study(ies) available for 3-hydroxyflavone and tamoxifen
| Article | Year |
|---|---|
Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Induction; Estrogen Antagonists; Female; Flavonoids; Flavonols; Genes, Reporter; Genistein; Humans; Luciferases; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1998 |
Estrogenic activities of Ginkgo biloba extracts.
Topics: Binding, Competitive; Cell Division; Cell Line; Cell Survival; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Non-Steroidal; Female; Flavonols; Gene Expression; Ginkgo biloba; Humans; Kaempferols; Membrane Proteins; Plant Extracts; Presenilin-2; Quercetin; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tamoxifen | 2004 |
Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson's disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; DEAD-box RNA Helicases; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Flavonols; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Morpholines; Oxidopamine; Parkinson Disease; Receptors, sigma; Ribonuclease III; Sigma-1 Receptor; Tamoxifen | 2020 |